Supplemental Information

6 Months Ended

Jun. 30, 2026

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Equity Method Investments

LACC, LLC Joint Venture

As of June 30, 2026, the Company owned an aggregate 50% membership interest in LACC, LLC ("LACC"). The Company accounts for its investment in LACC under the equity method of accounting and the change for the six months ended June 30, 2026 was as follows:


	Investment in LACC





Balance at December 31, 2025	$	991


Depreciation and amortization	(27)

Balance at June 30, 2026	$	964

Contract Liabilities and Remaining Performance Obligations

In May 2022, the Company entered into a chlorine and hydrogen chloride exchange contract with one of its customers. In the third quarter of 2025, the Company received an up-front payment of $70, representing a fixed portion of the total transaction price. The up-front fee was recorded as a contract liability and will be recognized ratably in net sales over the 20-year contract period. In addition to the fixed portion of the transaction price, the Company charges certain variable fees under the contract.

The total contract liabilities, primarily included in other liabilities on the balance sheet, were as follows:


	Six Months Ended June 30,
	2026		2025
Balance at January 1,	$	147	$	62
Revenues recognized that were included in the contract liability balances at the beginning of the period	(4)		(2)
Increases due to cash received and due, excluding amounts recognized as revenues during the period	15		—
Balance at June 30,	$	158	$	60

As of June 30, 2026, the remaining performance obligations were $185, representing the fixed components of the transaction price, expected to be recognized over the remaining term of the Company's revenue contracts.

Other Assets, Net

Other assets, net were $761 and $784 at June 30, 2026 and December 31, 2025, respectively. Deferred turnaround costs, net of accumulated amortization, included in other assets, net were $397 and $433 at June 30, 2026 and December 31, 2025, respectively.

Accrued and Other Liabilities

Accrued and other liabilities were $1,429 and $1,490 at June 30, 2026 and December 31, 2025, respectively. Accrued rebates and accrued operating lease liability, which is a component of accrued and other liabilities, was $239 and $128 at June 30, 2026 and $225 and $138 at December 31, 2025, respectively. No other component of accrued and other liabilities was more than five percent of total current liabilities. Accrued liabilities with related parties were $22 and $31 at June 30, 2026 and December 31, 2025, respectively.

Restructuring, Transaction and Integration-Related Costs

Restructuring, transaction and integration-related expenses for the three and six months ended June 30, 2026, were $3 and $21, respectively, and primarily related to the closures of the Pernis facility, certain North American chlorovinyls facilities and a styrene facility. Restructuring, transaction and integration-related expenses for the three and six months ended June 30, 2025, were $115 and $122, respectively, and primarily comprised of closure costs associated with the Pernis facility and the PVC resin unit at the Suzhou Huasu Plastics plant located in China.

Pernis Facility Closure

The Company ceased operations of its Pernis facility in 2025. The total costs recognized by the Company in 2025 as a result of this closure was $247, which comprised of $15 related to inventory write-off, in addition to asset retirement obligations, severance and separation costs and contract termination and other plant shutdown costs. The Company expects to recognize additional charges related to severance and separation costs of $4 in future periods in connection with the plant closure. The Company expects to complete the closure plan by the end of 2030. Asset retirement obligations and plant shutdown costs recorded represent management's best estimate based on information currently available and are subject to change as additional information becomes available.

The following table sets forth the accrual activity related to the closure of the Pernis facility included in accrued and other liabilities, and other liabilities in the Company's consolidated balance sheets and the cumulative charges recognized:


	Asset Retirement Obligations		Severance and Separation Costs		Contract Termination and Other Costs		Total
Balances at December 31, 2025	$	99	$	25	$	102	$	226
2026 charges and change in estimates	4		2		(2)		4
Payments	(13)		(11)		(4)		(28)
Foreign currency translation	(2)		—		(2)		(4)
Balances at March 31 2026	88		16		94		198
2026 charges and change in estimates	(3)		1		(2)		(4)
Payments	(11)		(2)		(4)		(17)
Foreign currency translation	(1)		(1)		—		(2)
Balances at June 30, 2026	$	73	$	14	$	88	$	175




Cumulative charges recognized as of June 30, 2026	$	123	$	30	$	154	$	307

Certain North American Chlorovinyls Facilities and Styrene Facility Closures

In December 2025, the Company ceased operations of certain of the Company's North American chlorovinyls production facilities, including (i) its polyvinyl chloride plant at the Aberdeen, Mississippi facility, (ii) its vinyl chloride monomer plant at the Lake Charles, Louisiana North facilities, and (iii) one of its diaphragm chlor-alkali units at the Lake Charles, Louisiana South facilities, as well as (iv) its styrene production plant located at the Lake Charles, Louisiana facilities. The total costs recognized by the Company in 2025 as a result of these closures was $393, which comprised of $287 related to accelerated depreciation and amortization and $30 related to asset write-offs, in addition to asset retirement obligations, severance and separation costs and other plant shutdown costs. The Company expects to recognize additional charges related to severance and separation costs of $1 and other plant shutdown costs of $6 in future periods in connection with these closures. The Company expects to complete the closure plan for these facilities by the end of 2027. Asset retirement obligations and plant shutdown costs recorded represent management's best estimate based on information currently available and are subject to change as additional information becomes available.

The following table sets forth the accrual activity related to the closure of the Chlorovinyls and Styrene facilities included in accrued and other liabilities, and other liabilities in the Company's consolidated balance sheets:


	Asset Retirement Obligations		Severance and Separation Costs		Other Plant Shutdown Costs		Total
Balances at December 31, 2025	$	52	$	17	$	7	$	76
2026 charges and change in estimates	—		3		8		11
Payments	(18)		(16)		(10)		(44)
Balances at March 31, 2026	34		4		5		43
2026 charges and change in estimates	2		1		4		7
Payments	(16)		(1)		(7)		(24)
Balances at June 30, 2026	$	20	$	4	$	2	$	26



Cumulative charges recognized as of June 30, 2026	$	54	$	21	$	19	$	94

Other Income, Net

Other income, net for all periods presented in the consolidated statement of operations, primarily comprised of interest income.

Supplemental Cash Flow Information

Right-of-use assets obtained in exchange for operating lease obligations were $83 and $90 for the six months ended June 30, 2026 and 2025, respectively.

Non-cash Investing Activities

Capital expenditure related liabilities, included in accounts payable and accrued and other liabilities, were $84 and $111 at June 30, 2026 and June 30, 2025, respectively.